Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function

James A Olzmann1, Keith Brown, Keith D Wilkinson

  • 1Departments of Pharmacology, Biochemistry, and Neurology, Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322-3090, USA.

Insights

Mutations in the DJ-1 protein cause early-onset Parkinson's disease. This study reveals DJ-1 acts as a cysteine protease, and the L166P mutation disrupts its structure and function, leading to disease.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Genetics

Background:

  • Mutations in DJ-1 are linked to autosomal recessive, early-onset familial Parkinson's disease.
  • The precise function of DJ-1 protein has remained largely unknown.
  • Understanding DJ-1's role is crucial for elucidating Parkinson's disease pathogenesis.

Purpose of the Study:

  • To investigate the biochemical function and structural properties of DJ-1 protein.
  • To elucidate the molecular mechanism by which Parkinson's disease-linked mutations in DJ-1 lead to neurodegeneration.

Main Methods:

  • Biochemical assays to assess protease and chaperone activity.
  • Site-directed mutagenesis (Cys-106 to Ala, L166P mutation).
  • Protein structural analysis, dimerization studies, ubiquitination assays, and proteasomal degradation studies.

Main Results:

  • DJ-1 functions as a dimeric cysteine protease, with activity dependent on Cys-106.
  • The L166P mutation disrupts DJ-1's folding, preventing dimerization and abolishing protease activity.
  • Misfolded L166P mutant DJ-1 is polyubiquitinated and degraded by the proteasome.

Conclusions:

  • DJ-1's function as a cysteine protease is essential for preventing Parkinson's disease.
  • Loss-of-function mutations, like L166P, cause protein misfolding, loss of catalytic activity, and subsequent degradation, leading to disease.
  • These findings provide critical insights into the molecular basis of DJ-1-associated Parkinson's disease.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...